Millions of multiple sclerosis patients have been treated with hyperbaric oxygen therapy. Many have benefited, we don't doubt. But here's a prime example of doctors and patients acting more on hope than on evidence.
The medical literature on HBOT for MS does not impress. Plenty of fine studies altogether have shown rarely significant and never sustainable health improvements. Nor can we find any reasonable hypothesis why HBOT should work. Still, in their Cochrane Review meta-analysis, Bennett and Heard call for larger randomized, multicenter trials. So do we. For the time being, though, our check lands firmly in "scant."
Jump to our new multiple sclerosis page to learn more and to use our HyperbaricLink Evidence Index to guide your personal research.